Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-007 · Risk modifiers
CV-08: High-sensitivity CRP
High-sensitivity CRP. Evaluates hs-CRP ≥ 2.0 mg/L, persistent.
Active rulePriority 6Cardio engine v1.0.0
Condition
- hs-CRP ≥ 2.0 mg/L, persistent
What it reports
- hs-CRP is a risk enhancer that informs a shared decision
Diagnostic boundary
- The JUPITER population does not define a treatment rule here.
Evidence
- EV-ACCAHA-CHOL-2018Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143.Supports: Risk categories, risk enhancers, statin benefit groups and the coronary-calcium decision aid Very-high-risk ASCVD definition
- EV-JUPITER-2008Ridker PM, Danielson E, Fonseca FAH, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med. 2008;359(21):2195-2207.Supports: hs-CRP ≥2 mg/L identified a population in whom a statin lowered events despite a low LDL-C
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.